Enact Holdings Inc. (ACT)

ACT Capital Advisors Represents Advanced Marketing Group, LLC on Its Acquisition by StoneX Commodity Solutions, LLC

Aduro Selects Saipem for Engineering and Procurement Support for First-of-a-Kind HCT Facility at Chemelot

Dividend Champion, Contender, And Challenger Highlights: Week August 16

Enact Holdings, Inc. (ACT) Q2 2026 Earnings Call Transcript

Enact Holdings, Inc. (ACT) Q2 Earnings and Revenues Top Estimates

Enact Reports Second Quarter 2026 Results; Announces $0.24 Quarterly Dividend

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

ACT Capital Advisors Secures Development Capital from Pathward and BridgePeak for Teichos Energy's Late-Stage Solar Energy Projects

Enact Holdings, Inc. (ACT) Reports Next Week: Wall Street Expects Earnings Growth

Aduro and ECOCE Complete Phase 1 Feedstock Mapping, Advance Mexico Plastics Collaboration to HCT Testing

Enact to Host Second Quarter 2026 Earnings Call August 6th

OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE

Aduro Clean Technologies Announces Closing of LIFE Offering

Aduro Clean Technologies Europe Signs MOU with Ortessa Groep BV to Advance FOAK Plant Feedstock Logistics

Aduro Clean Technologies Announces Filing of Amended and Restated LIFE Offering Document Following Closing of Public Offering

Aduro Clean Technologies Announces Closing $15.54 Million Underwritten Public Offering

Aduro Clean Technologies Announces Pricing of US$15.64 Million Underwritten Public Offering and Concurrent Private Placement of up to US$7.17 Million

Enact Holdings Continues To Be The Driver For Genworth Financial

Aduro Clean Technologies Inc. (ACT) Opens the Market

Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs